IASO207 Injection

DRUG2 trials

Sponsors

Peking University People's Hospital

Conditions

MalignanciesREFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Early Phase 1

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

RecruitingNCT07574346

Peking University People's HospitalMalignancies

Start: 2026-05-29End: 2042-04-30Target: 18Updated: 2026-06-18

IASO207 Injection for Active Refractory Systemic Lupus Erythematosus (SLE)

RecruitingNCT07617740

Peking University People's HospitalREFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS

Start: 2026-05-25End: 2030-05-30Target: 18Updated: 2026-06-01